February 12, 2024 12:57 PM EST

FDA addresses expanded use of data monitoring committees in draft guidance

The FDA laid out considerations for how sponsors should leverage committees to help analyze clinical trial data in draft guidance

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA ad­dress­es ex­pand­ed use of da­ta mon­i­tor­ing com­mit­tees in draft guid­ance